R&G Pharmastudies Co. Ltd. logo

R&G Pharmastudies Co. Ltd. (301333)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
62. 61
+4.61
+7.9483%
¥
5.43B Market Cap
- P/E Ratio
0.64% Div Yield
9.82M Volume
- Eps
¥ 58
Previous Close
Add Transaction
Day Range
57.4 69
Year Range
43.79 91.78
Want to track 301333 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

301333 closed today higher at ¥62.61, an increase of 7.9483% from yesterday's close, completing a monthly increase of 27.2561% or ¥13.41. Over the past 12 months, 301333 stock gained 4.8919%.
301333 is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2025, exceeded the consensus estimates by 0.3603%. On average, the company has surpassed earnings expectations by 0.2423%, based on the last three reports.
R&G Pharmastudies Co. Ltd. has completed 1 stock splits, with the recent split occurring on Jun 29, 2023.
The company's stock is traded on one exchange.

301333 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

R&G Pharmastudies Co. Ltd. (301333) FAQ

What is the stock price today?

The current price is ¥62.61.

On which exchange is it traded?

R&G Pharmastudies Co. Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 301333.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.64%.

What is its market cap?

As of today, the market cap is 5.43B.

Has R&G Pharmastudies Co. Ltd. ever had a stock split?

R&G Pharmastudies Co. Ltd. had 1 splits and the recent split was on Jun 29, 2023.

R&G Pharmastudies Co. Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Jie Wu M.B.A. CEO
XSHE Exchange
CNE100005K44 ISIN
CN Country
2,208 Employees
8 Jul 2025 Last Dividend
29 Jun 2023 Last Split
- IPO Date

Overview

R&G PharmaStudies Co., Ltd. is a company based in Beijing, China, specializing in providing comprehensive clinical research outsourcing services. Catering to pharmaceutical and medical device companies as well as scientific research institutions within China, R&G PharmaStudies offers a wide range of services aimed at enhancing the efficiency and effectiveness of clinical trials. Since its establishment in 2008, the company has been dedicated to supporting the development and research efforts of its clients through specialized services covering various aspects of clinical trials, including consultation, operation, data management, statistical analysis, and site management.

Products and Services

  • Clinical Trial Consulting

    Expert advice on clinical trial design, regulatory requirements, and strategy to ensure effective and compliant study implementation.

  • Clinical Trial Operation

    Comprehensive management services that encompass planning, execution, and monitoring of clinical trials to achieve study goals efficiently.

  • Data Management and Statistical Analysis

    Management of clinical trial data through systematic processing, along with advanced statistical analysis to ensure data integrity and insightful analysis.

  • Technical Services and Solutions

    Provision of technological support and innovative solutions for various challenges encountered during clinical trial operations.

  • Biostatistical Quantitative Scientific Support

    Application of biostatistical methods to support scientific research, ensuring rigorous quantification and analysis of research data.

  • Clinical Trial Data Monitoring Committee Services

    Offering services related to the data monitoring committee of clinical trials including participation in the committee or performing relevant statistical analysis for the committee.

  • Clinical Pharmacology Services

    Specialized pharmacological support throughout the drug development process, focusing on the pharmacokinetics and pharmacodynamics of compounds.

  • Biological Sample Testing Services

    Advanced testing services to analyze and detect biological samples collected during clinical trials for determining the concentration of the original drug and/or its metabolites.

  • Clinical Trial Site Management Services

    Management and oversight of clinical trial sites to ensure compliance, efficiency, and high standards of data collection and participant care.

Contact Information

Address: North Tower, Beijing, China, 100048
Phone: 86 10 8801 8650